|
Volumn 13, Issue 2, 2000, Pages 193-198
|
Cost of antibiotic therapy in neutropenic patients undergoing peripheral blood stem cell transplantation for breast cancer;Coste del tratamiento antibiotico empirico en pacientes neutropenicas sometidas a trasplante de progenitores hematopoyeticos pot cancer de mama
a a a a a |
Author keywords
Cost; Febrile neutropenia; Peripheral blood cell transplantation
|
Indexed keywords
ANTIBIOTIC AGENT;
TEICOPLANIN;
VANCOMYCIN;
AMIKACIN;
ANTINEOPLASTIC AGENT;
DRUG DERIVATIVE;
PENICILLANIC ACID;
PIPERACILLIN;
TAZOBACTAM;
ANTIBIOTIC PROPHYLAXIS;
ARTICLE;
BREAST CANCER;
DRUG COST;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
INFECTION;
INFECTION RISK;
MAJOR CLINICAL STUDY;
NEUTROPENIA;
RESOURCE ALLOCATION;
BACTERIAL INFECTION;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
DRUG COMBINATION;
ECONOMICS;
FEMALE;
FEVER;
GRAM NEGATIVE INFECTION;
HOSPITAL COST;
IMMUNOSUPPRESSIVE TREATMENT;
SPAIN;
TREATMENT FAILURE;
TREATMENT OUTCOME;
AMIKACIN;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
DRUG COSTS;
DRUG THERAPY, COMBINATION;
FEMALE;
FEVER;
GRAM-NEGATIVE BACTERIAL INFECTIONS;
GRAM-POSITIVE BACTERIAL INFECTIONS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HOSPITAL COSTS;
HUMANS;
NEUTROPENIA;
PENICILLANIC ACID;
PIPERACILLIN;
SPAIN;
TEICOPLANIN;
TRANSPLANTATION CONDITIONING;
TREATMENT FAILURE;
TREATMENT OUTCOME;
VANCOMYCIN;
|
EID: 0033929402
PISSN: 02143429
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (23)
|